Evidence map›Paper›PMID 41553471›Full record

Observational studyJournal of neural transmission (Vienna, Austria : 1996)2026

Nonmotor symptoms of craniocervical dystonia: a multicentre international study-using the Dystonia nonmotor symptoms questionnaire.

Karolina Poplawska-Domaszewicz, Sonja Boshnjak, Carmen Martín de la Morena, Carmen Rodriguez-Blazquez, Krzysztof Sroka, Robert Narożny, Mubasher Qamar, Lucia Batzu, Vinay Goyal, Vinod Metta and 2 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Karolina Poplawska-DomaszewiczDepartment of Neurology, Poznan University of Medical Sciences, 60-355, Poznan, Poland. karolina.poplawska@usk.poznan.pl.
Sonja BoshnjakParkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.
Carmen Martín de la MorenaParkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.
Carmen Rodriguez-BlazquezNational Centre of Epidemiology and CIBERNED, Institute of Salud Carlos III, Madrid, Spain.
Krzysztof SrokaDepartment of Neurology, Poznan University of Medical Sciences, 60-355, Poznan, Poland.
Robert NarożnyDepartment of Neurology, Poznan University of Medical Sciences, 60-355, Poznan, Poland.
Mubasher QamarParkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.
Lucia BatzuParkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.
Vinay GoyalInstitute of Movement Disorders and Parkinson's Centre, Medanta Hospitals, New Delhi, India.
Vinod MettaParkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.
K Ray ChaudhuriDementech Neuroscience Clinical Academic Centre, London, UK.
Lisa KlingelhoeferAllgemeine Neurologie und Parkinson Spezialklinik, KTW Klinik Am Tharandter Wald GmbH, Hetzdorf, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-motor symptoms (NMS) are increasingly recognized as significant contributors to the overall burden of craniocervical dystonia (CCD), yet they remain underdiagnosed. This international, multi-centre observational study aimed to evaluate the prevalence and burden of NMS in 167 patients with adult-onset idiopathic CCD across Poland, the UK, and Germany, using the validated Dystonia Non-Motor Symptoms Questionnaire (DNMSQUEST). Participants were assessed at the end of their botulinum neurotoxin treatment cycle. The majority of patients (94.6%) reported at least one NMS, and over half experienced five or more, with pain (62.3%) and sleep dysfunction (68.8%) being the most common. Emotional disturbances, including anxiety (34.7%) and depression (35.9%), were also prevalent. The total DNMSQUEST score averaged 5.9 ± 3.8. NMS burden was categorized as low in 42.5%, medium in 35.3%, and high in 22.2% of patients. Combined cervical and cranial dystonia was associated with the highest NMS burden (mean DNMSQUEST score 9.28 ± 3.09). NMS were significantly more prevalent in CCD compared to a small healthy control group. Sleep dysfunction and pain were strongly correlated with higher total NMS scores. Impairments in activities of daily living (69.5%) and a substantial proportion of patients (49.7%) reported balance and gait difficulties. Comparisons with prior DNMSQUESTQ validation cohorts revealed similar symptom patterns, supporting the cross-cultural applicability of the questionnaire. This study highlights the significant and multifaceted burden of NMS in CCD and underscores the importance of incorporating structured NMS assessment into routine clinical care. Particular attention should be paid to sleep dysfunction and pain, which appear to be central to the NMS burden in CCD.

Indexed as

Dystonic DisordersPainSleep Wake DisordersTorticollisAdultAgedBotulinum ToxinsFemaleGermanyHumansMaleMiddle AgedPolandSurveys and QuestionnairesSymptom BurdenBotulinum ToxinsBotulinum toxinDystoniaDystonia nonmotor symptoms questionnairePainSleep

Identifiers

PMID41553471
PMCPMC13149578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.